- Home
- DYAI vs BEAT Comparison
DYAI vs BEAT Comparison
Compare DYAI & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DYAI | BEAT |
|---|---|---|
| Founded | 1979 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.5M | 27.7M |
| IPO Year | 2003 | 2021 |
Fundamental Metrics
Financial Performance| Metric | DYAI | BEAT |
|---|---|---|
| Price | $0.69 | $0.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $3.00 | ★ $5.63 |
| AVG Volume (30 Days) | 162.2K | ★ 397.6K |
| Earning Date | 05-13-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 15.07 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $3,090,345.00 | N/A |
| Revenue This Year | $122.79 | N/A |
| Revenue Next Year | $100.00 | $315.97 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.65 | $0.47 |
| 52 Week High | $1.60 | $4.00 |
Technical Indicators
Market Signals| Indicator | DYAI | BEAT |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 39.50 |
| Support Level | N/A | N/A |
| Resistance Level | N/A | $0.63 |
| Average True Range (ATR) | 0.00 | 0.03 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 7.78 |
Price Performance
Historical ComparisonAbout DYAI Dyadic International Inc.
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.